ArticleJournal of animal science2026
Effects of dietary 25-hydroxyvitamin D3 (25(OH)D3) supplementation on production performance, egg quality, tibia quality, and mineral metabolism of ducks during peak laying period in the cage rearing system.
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
25-Hydroxyvitamin D3 (25(OH)D3) has been reported to improve production performance and egg quality in ducks during the late laying period, but its effects during the peak laying period remain rarely studied. The aim of this study was to investigate the effects of dietary 25(OH)D3 supplementation on the production performance, egg quality, tibia quality, and mineral metabolism of ducks during the peak laying period in a cage rearing system. A total of 360 Liancheng white laying ducks at 30 weeks (wk) of age were randomly assigned to 5 groups, each consisting of 6 replicates with 12 ducks per replicate. Ducks were fed a basal diet with 25(OH)D3 supplementation at 0, 1,000, 2,000, 3,000, and 4,000 IU/kg throughout the trial for 8 wk. One-way ANOVA was employed to assess the influence of supplementation level, and linear and quadratic regression analyses were performed for statistical evaluation of dose-dependent effects. 25(OH)D3 supplementation linearly and quadratically increased the laying rate, average egg weight, and egg mass and quadratically decreased the feed conversion ratio (FCR). The mean of eggshell strength and thickness at 4 and 8 wk increased linearly and quadratically with increasing 25(OH)D3 levels, and the 4000 IU/kg 25(OH)D3 increasing the eggshell thickness by 5.7% (at 4 wk) and 2.9% (mean of those at 4 and 8 wk) relative to those of the non-supplemented group. At the end of weeks 4 and 8 of the trial, serum 25(OH)D3, bone glutamyl protein (BGP), and carbonic anhydrase (CA) increased linearly (P < 0.05), and serum parathyroid hormone (PTH) decreased linearly (P < 0.05); the 4000 IU/kg group had the highest serum 25(OH)D3 (4.24 ng/mL) and BGP (3.11 ng/mL) concentrations at 8 wk. Additionally, the tibial breaking strength, trabecular bone number, BGP content, alkaline phosphatase (ALP) activity, and mRNA levels increased linearly with 25(OH)D3 supplementation (P < 0.05). The optimal dietary 25(OH)D3 supplementation levels were approximately 2,355, 2,347 and 3,269 IU/kg on the basis of the quadratic model of the laying rate, FCR and eggshell strength, respectively. In summary, 25(OH)D3 supplementation improved the production performance and eggshell quality of ducks during the peak laying period by maintaining calcium and phosphorus homeostasis and enhancing tibia quality. A diet that contains 2,347-3,269 IU/kg of 25(OH)D3 displayed beneficial effects on maintaining calcium and phosphorus homeostasis and improving the tibial quality, which was recommended for ducks during peak laying period in the cage rearing system (30-38 wk of age).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.